Task: Answer the multiple-choice question.
Question: Which compound exhibits a -30.381% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) O=S1(=O)CCOCCCN1Cc1ccccc1F
(b) CCn1c(N2CCN(C(=S)NCC(C)C)CC2)nc2ccccc21
(c) COc1ccc2cc(C(c3nnnn3C3CCCC3)N3CCOCC3)c3nnnn3c2c1
Answer: b. CCn1c(N2CCN(C(=S)NCC(C)C)CC2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(N2CCN(C(=S)NCC(C)C)CC2)nc2ccccc21
CCn1c(N2CCN(C(=S)NCC(C)C)CC2)nc2ccccc21
4-(1-ethylbenzimidazol-2-yl)-N-(2-methylpropyl)piperazine-1-carbothioamide